Tectonic Therapeutic Inc. is a biotechnology company developing GPCR -targeted therapeutic proteins. Tectonic Therapeutic Inc., formerly known as AVROBIO Inc., is based in CAMBRIDGE, Mass.
| Revenue (Most Recent Fiscal Year) | -- |
| Net Income (Most Recent Fiscal Year) | $-57.98M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | -- |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.39 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -- |
| Net Margin (Trailing 12 Months) | -- |
| Return on Equity (Trailing 12 Months) | -30.13% |
| Return on Assets (Trailing 12 Months) | -27.52% |
| Current Ratio (Most Recent Fiscal Quarter) | 22.92 |
| Quick Ratio (Most Recent Fiscal Quarter) | 22.92 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | -- |
| Book Value per Share (Most Recent Fiscal Quarter) | $16.12 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.93 |
| Earnings per Share (Most Recent Fiscal Year) | $-6.65 |
| Diluted Earnings per Share (Trailing 12 Months) | $-7.31 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Common Shares Outstanding | 18.67M |
| Free Float | 11.58M |
| Market Capitalization | $418.26M |
| Average Volume (Last 20 Days) | 0.17M |
| Beta (Past 60 Months) | 3.44 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 38.00% |
| Percentage Held By Institutions (Latest 13F Reports) | 62.63% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |